COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

COMparison Between All immunoTherapies for Multiple Sclerosis. (COMBAT-MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03193866
Recruitment Status : Active, not recruiting
First Posted : June 21, 2017
Last Update Posted : March 13, 2020
Patient-Centered Outcomes Research Institute
Kaiser Foundation Research Institute
Information provided by (Responsible Party):
Fredrik Piehl, Karolinska Institutet

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 30, 2022
Estimated Study Completion Date : December 31, 2022